Related references
Note: Only part of the references are listed.The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease
Wei-Chung Chiou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
Katherine A. Twohig et al.
LANCET INFECTIOUS DISEASES (2022)
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging
Wioletta Rut et al.
NATURE CHEMICAL BIOLOGY (2021)
Characteristics of SARS-CoV-2 and COVID-19
Ben Hu et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Potential SARS-CoV-2 main protease inhibitors
Riddhidev Banerjee et al.
DRUG DISCOVERY TODAY (2021)
Potential inhibitors of SARS-CoV-2: recent advances
Ghazaleh Jamalipour Soufi et al.
JOURNAL OF DRUG TARGETING (2021)
What coronavirus 3C-like protease tells us: From structure, substrate selectivity, to inhibitor design
Muya Xiong et al.
MEDICINAL RESEARCH REVIEWS (2021)
Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2
Shiling Hu et al.
JOURNAL OF MEDICAL VIROLOGY (2021)
Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry
Dingqi Zhang et al.
PHARMACOLOGICAL RESEARCH (2021)
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19
Dafydd R. Owen et al.
SCIENCE (2021)
A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication
Shin-ichiro Hattori et al.
NATURE COMMUNICATIONS (2021)
X-ray screening identifies active site and allosteric inhibitors of SARS-CoV-2 main protease
Sebastian Guenther et al.
SCIENCE (2021)
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas et al.
NATURE (2021)
Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
Haixia Su et al.
NATURE COMMUNICATIONS (2021)
Epigallocatechin gallate from green tea effectively blocks infection of SARS-CoV-2 and new variants by inhibiting spike binding to ACE2 receptor
Jinbiao Liu et al.
CELL AND BIOSCIENCE (2021)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur
Zhenming Jin et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics
Qingke Li et al.
CELL (2020)
An Activity-Guided Map of Electrophile-Cysteine Interactions in Primary Human T Cells
Ekaterina V. Vinogradova et al.
CELL (2020)
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
Lifeng Fu et al.
NATURE COMMUNICATIONS (2020)
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
Alice Douangamath et al.
NATURE COMMUNICATIONS (2020)
Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site
Jaeyong Lee et al.
NATURE COMMUNICATIONS (2020)
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
Mei-Yue Wang et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)
Recent Development of Oridonin Derivatives with Diverse Pharmacological Activities
Weiyan Cheng et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2019)
Salvia miltiorrhiza Burge (Danshen): a golden herbal medicine in cardiovascular therapeutics
Zhuo-ming Li et al.
ACTA PHARMACOLOGICA SINICA (2018)
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
Hongbin He et al.
NATURE COMMUNICATIONS (2018)
Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review
Ren-You Gan et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2018)
Demystifying traditional herbal medicine with modern approaches
Fu-Shuang Li et al.
NATURE PLANTS (2017)
Mechanism-based inactivation of human cytochrome P450 enzymes and the prediction of drug-drug interactions
R. Scott Obach et al.
DRUG METABOLISM AND DISPOSITION (2007)
Design of wide-spectrum inhibitors targeting coronavirus main proteases
HT Yang et al.
PLOS BIOLOGY (2005)